Neuron-glial interactions and mental health Flashcards

1
Q

Do glial cells affect behaviour?

A

Yes

e. g. Mice with human astrocytes
- perform better at cognitive tasks
- show enhanced long term potentiation (LTP) of synapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 ways astrocytes can affect behaviour?

A
  1. Homeostatic role
  2. Ability to release NTs -> gliotransmission
  3. Formation of astrocytic networks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the components of the tripartite synapse?

A
  • Pre-synaptic neuron: releases NTs
  • Post-synaptic neuron
  • Astrocyte: reacts to NTs with elevation of Ca++ (<=> Ca2+)
    • Ca++ increases in astrocytes elicit the regulated release of gliotransmitters, e.g. glutamate, GABA, ATP and adenosine (purines), D-serine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the process of gliotransmission in the tripartite synapse?

A
  • Astrocyte reacts to NTs with elevation of Ca2+
  • Ca2+ increase -> regulated release of calcium-dependent gliotransmitters (e.g. Glu, GABA, ATP, D-serine)

=> Astrocytes control neuronal excitability and synaptic transmission through calcium-dependent gliotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 2 possible consequences of gliotransmission, supported by evidence?

A

Role in memory and sleep regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the evidence for a role of astrocytes in memory?

A

Han et al. (2012): Mice model mutated: lacking type 1 cannabinoid receptor (CB1R) in astroglial cells vs. Glu neurons vs. GABA neurons:

  • Spatial working memory impaired in mice lacking CB1R on Glu or GABA neurons ; BUT preserved in mice lacking CB1R on astroglial cells
  • Long term depression (LTD) impaired in mice lacking CB1R on Glu or GABA neurons ; BUT preserved in mice lacking CB1R on astroglial cells

Explanation: cannabinoid exposure in vivo sequentially activated astroglial CB1R

  • astrocytes release Glu
  • Glu binds to NMDA receptors
  • AMPA receptor is internalised
  • LTD is induced
  • > mouse is lost (spatial working memory impaired)

=> Astrocytes can play an active role in cognition, and a role in its impairment in pathological states

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the evidence for the role of astrocytes in sleep regulation?

A

Adenosine plays a role in sleep homeostasis

  • Studies show adenosine comes from astrocytes
  • Astrocytes release gliotransmitters like ATP, which is converted extracellularly into adenosine
  • This exocytotic release is dependent of the SNARE protein
    > Genetic modification can abolish this SNARE-dependent release of gliotransmitters
  • in mice: prevents both tonic and activity dependent extracellular accumulation of adenosine, which acts on A1 receptor
    -> role of gliotransmitters (here ATP) in sleep regulation
    -> Astrocytes modulate behaviour ; A1R role in regulation of sleep homeostasis

> Cognitive decline associated with sleep loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the evidence that gap junctions interconnect astrocytes into networks?

A
  • Astrocyte-astrocyte communication via gap junctions which allow passage of ions -> direct inter-cellular communication
  • Astrocytic gap junctions are made by 2 proteins: connexin-30 and connexin-43
  • Study of the coupling of astrocytes into networks by injecting fluorescent dye (e.g. biocytin) in astrocytes
    -> gap junctions show selective permeability which can be regulated
  • Permeability is age and region-specific
    > Transgenic animals that had both connexin-30 and connexin-43 knocked out, are unable to form gap junctions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are astrocytic networks formed and affect neuronal activity?

A

Example with Glutamatergic synapses

  1. Release of NT from pre-synaptic Glu neuron
  2. NT interacts with receptors on astrocytes -> Ca2+ increase
  3. Gliotransmitters are released in astrocytes undergoing Ca2+ increase -> influence neuronal activity
  4. Glu and its derivative glutamine diffuse through astrocyte gap junctions
    - > rise in Ca2+ spreads to neighbouring astrocytes = ‘calcium wave’
  5. Release of gliotransmitters at a remote synapse -> affects the activity of underlying neuronal networks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can astrocytic networks do?

A

> Regulate the generation of a rhythmic firing pattern in neurons, necessary for vital functions such as respiration and mastication

> Act as a hub for integrating signals from different brain areas
- Pereira and Furlan (2010): astrocytic networks are essential for voluntary behaviour ; only automatic behaviour could be executed purely by neuronal network

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 main lines of evidence on astrocytes and depression?

A
  • Human studies: mainly post-mortem
  • Animal studies, including genetically modified animals
  • Astrocytes in culture (In vitro) studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the proposed neurophysiological processes underlying a depressed state?

A
  • Monoamine hypothesis
  • Dysfunction of HPA axis, involved in the response to stress, may be implicated in the pathophysiology of depression
  • Circadian rhythm abnormalities: disruption of sleep patterns
  • Neurodegenerative and neuroinflammation alteration may be contributing factors, especially in late onset depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the current statistics on pharmacological treatments efficacy?

A
  • Between 30 and 50% of people with depression will not respond to anti depression medication
  • About 50% of sufferers are poor responders to pharmacotherapy in general
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the evidence from animal studies on astrocytes’ role in depression?

A
  • Astrocyte pathology is present in animal models of depression
  • Treatments that revert astrocyte pathology also revert symptoms of depression in animal models
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does the study on chronic unpredictable stress (CUS) on an animal model of depression show?

A

> Animals are subjected to a sequence of 2 stressors per day over an extended time period
> Authors measured level of mRNA for a specific marker of astrocytes: glial fibrillary associated protein (GFAP)

  • > Significant decrease of mRNA levels seen for the glial-specific marker GFAP
  • > Effect of stress can be reversed by the glutamate-modulating drug Riluzole

> CUS affects animal behaviour in the sucrose preference test, leading to anhedonia (reduced preference for sucrose solution)
- reversed by Riluzole, in parallel with reduction observed in glial pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does Riluzole reverse glial pathology and depressive behaviour?

A

Riluzole increases Glu uptake by astrocytes -> increased glutamine production
- therapeutic in the context of depression

Studies show patients with MDD exhibit reduced cortical levels of GABA NTs - similar to the rats undergoing CUS

  • normalising GABA levels = clinical improvement
  • GABA neuronal synthesis requires glutamine - produced by astrocytes

=> Dysregulation of astrocytic support of the GABAergic transmission contributes to the pathophysiology of MDD
-> therapeutic targets

17
Q

What does the human post-mortem material obtained from depression suicides show?

A

Authors measured level of mRNA and protein for the astrocytic specific marker GFAP in various brain areas

  • Decreased mRNA and protein level for GFAP in mediodorsal thalamus and caudate nucleus
  • BUT not primary motor and visual cortex, or the cerebellum

=> Presence of astrocytic pathology in areas involved in mood regulation

18
Q

What does the study on the effect of Fluoxetine (Prozac) on cultured astrocytes show?

A

> Direct effect of Fluoxetine (SSRI) on cultured astrocytes:
- induces production of trophic factors by cultured astrocytes in serotonin dependent manner

> Full therapeutic effect of Fluoxetine my be delayed until 4 to 6 weeks

=> Presence of a glial pathology - probably astrocytic atrophy - in depression

  • correlates with the depressive symptoms in humans and animal models
  • BUT there is no causal link between astrocytic pathology and depression
19
Q

In the study on the effect of Fluoxetine (Prozac) on cultured astrocytes, what may explain the therapeutic delay?

A

If the main effect of Fluoxetine (Prozac) is on astrocytes via induction of the production of trophic factors:
- it would take some time for the increasing trophic factor to lead to increasing uptake plasticity, neurogenesis and restauration of damaged neuronal network

20
Q

What does the human post-mortem material obtained from suicide completers with MDD, BD or schizophrenia show?

A

Dysfunction of astrocytic networks in depressed individuals
- expression of the components of astrocytic gap junctions connexin-30 and connexin-43 is reduced in dorsal lateral PFC of suicide completers (vs. controls)

21
Q

What does the study on the effect of antidepressants on chronic unpredictable stress in rats show?

A

> CUS in rats causes decreased connexin-43 protein and mRNA levels in the PFC
> Antidepressants (Fluoxetine and Duloxetine) reverse this decrease
- Cx43 protein and mRNA levels restored to normal

22
Q

What does the study on the effect of CUS on astrocytic networks in rats show?

A

> CUS disrupts astrocytic networks
- significant decrease in the distance of diffusion and the number of coupled cells in the prelimbic cortex of CUS-exposed rats

> Treatment with antidepressants (Fluoxetine and Duloxetine) significantly reversed the effect of CUS on intercellular coupling

23
Q

What its the consequence of blocked gap junctions in the PFC in the study with animal models?

A

Authors infused the chemical carbenoloxone, which blocks gap junction in the prefrontal cortex
- induces depressive-like behaviour

Measured with sucrose preference test:

  • Animals that had a control infusion (saline), displayed a preference for sucrose solution
  • this was decreased, indicating depressive-like symptoms already at the lowest dose of carbenoloxone
  • with increased doses, depressive symptoms became more apparent

=> Astrocytic network dysfunction may be sufficient to induce the onset of depression